An economic and environmentally friendly approach of overcoming the problem of fossil CO 2 emissions would be to reuse it through fixation into biomass. Carbon dioxide (CO 2 ), which is the basis for the formation of complex sugars by green plants and microalgae through photosynthesis, has been shown to significantly increase the growth rates of certain microalgal species. Microalgae possess a greater capacity to fix CO 2 compared to C 4 plants. Selection of appropriate microalgal strains is based on the CO 2 fixation and tolerance capability together with lipid potential, both of which are a function of biomass productivity. Microalgae can be propagated in open raceway ponds or closed photobioreactors. Biological CO 2 fixation also depends on the tolerance of selected strains to high temperatures and the amount of CO 2 present in flue gas, together with SO x and NO x . Potential uses of microalgal biomass after sequestration could include biodiesel production, fodder for livestock, production of colorants and vitamins. This review summarizes commonly employed microalgal species as well as the physiological pathway involved in the biochemistry of CO 2 fixation. It also presents an outlook on microalgal propagation systems for CO 2 sequestration as well as a summary on the life cycle analysis of the process.
Industries produce millions of cubic meters of effluent every year and the wastewater produced may be released into the surrounding water bodies, treated on-site or at municipal treatment plants. The determination of organic matter in the wastewater generated is very important to avoid any negative effect on the aquatic ecosystem. The scope of the present work is to assess the physicochemical composition of the wastewater produced from one of the brewery industry in South Africa. This is to estimate the environmental impact of its discharge into the receiving water bodies or the municipal treatment plant. The parameters monitored for the quantitative analysis of brewery wastewater include biological oxygen demand (BOD5), chemical oxygen demand (COD), total suspended solids, volatile suspended solids, ammonia, total oxidized nitrogen, nitrate, nitrite, phosphorus and alkalinity content. In average, the COD concentration of the brewery effluent was 5340.97 mg/l with average pH values of 4.0 to 6.7. The BOD5 and the solids content of the wastewater from the brewery industry were high. This means that the effluent is very rich in organic content and its discharge into the water bodies or the municipal treatment plant could cause environmental pollution or damage the treatment plant. In addition, there were variations in the wastewater composition throughout the monitoring period. This might be as a result of different activities that take place during the production process, as well as the effects of peak period of beer production on the water usage.
This study was aimed at using the Central Composite Design (CCD) and Box-Behnken Design (BBD) to compare the efficiency and to elucidate the main interacting parameters in the upflow anaerobic sludge blanket (UASB) reactor, namely: Organic Loading Rate (OLR), Hydraulic Retention Times (HRT) and pH at a constant temperature of 35°C. Optimum HRT (15 h), OLR (3.5 kg.m-3 .d-1) and pH (7) resulted in biogas production of 5,800 mL/d and COD removal of 80.8%. BBD produced a higher desirability efficiency of 94% as compared to the CCD which was 92%. The regression quadratic models developed with high R 2 values of 0.961 and 0.978 for both CCD and BBD, respectively, demonstrated that the interaction models could be used to pilot the design space. BBD model developed was more reliable with a higher prediction of biogas production (5,955.4 ± 225.3 mL/d) and COD removal (81.5 ± 1.014%), much close to the experimental results at a 95% confidence level. CCD model predictions was greater in terms of COD removal (82.6 ± 1.06% > 80.8%) and biogas production (4,636.31 mL/d ± 439.81 < 5,800 mL/d) which was less than the experimental results. Therefore, RSM can be adapted for optimizing various wastewater treatment processes.
Antibiotics and other emerging contaminants are removed by wastewater treatment plants (WWTPs) to a certain extent. However, the removal mechanism is not well understood due to the fact that the majority of the WWTPs only focus on the occurrence of these contaminants in the influents and effluents and sometimes in the sludge. Understanding the removal pathway is therefore difficult. This study is aimed at investigating the removal pathways of selected veterinary antibiotics from wastewater. A laboratory scale upflow anaerobic sludge blanket (UASB) reactor was employed to treat synthetic wastewater to explore the removal efficiencies of five veterinary antibiotics with an initial concentration of 50 µg/L. In a like manner, batch reactors were further used to evaluate the removal routes of the antibiotics. The UASB reactor was operated continuously under mesophilic conditions to evaluate its performance with regards to the removal of organics and at the same time monitor biogas production. Organic loading rate (OLR) was varied from 8 to 9.2 kg.COD.m -3 .d -1 while keeping the hydraulic retention time (HRT) constant at 12 h. A COD removal efficiency higher than 75% was achieved at an OLR of 9 kg.COD.m -3 .d -1 , with a HRT of 12 hours. About 80% of the antibiotics were removed during the continuous processes, however, a distinctive pattern of removal was not observed. The kinetic studies using batch reactors showed that the removal route for the antibiotics was majorly adsorption to the sludge. Biodegradation occurred alongside adsorption but to a lesser degree. The kinetic data showed that the antibiotics followed a first order kinetic model with half-lives that ranged from 6 to 77 days.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.